Clinical trial
Novel Method for Diagnosis of Neurodegenerative Diseases Based on Saliva Biochemical Profiling
NCT06869135 is registered in ClinicalTrials.gov with Fondazione Don Carlo Gnocchi ETS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Method for Diagnosis of Neurodegenerative Diseases Based on Saliva Biochemical Profiling
- Lead sponsor
- Fondazione Don Carlo Gnocchi ETS
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 24, 2025
- Completion date
- December 15, 2027
- Enrollment
- 242 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, mild cognitive impairment (mci), neurodegenerative diseases, parkinson disease, parkinsonism, prodromal parkinson's disease